These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6477682

  • 1. Anti-tumor effect of a streptococcal preparation (OK-432). 1. Positive co-relation between the anti-tumour effect and delayed type hypersensitivity reaction to OK-432 in mice.
    Makidono R, Matsuura K, Makidono A.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Feb 25; 44(2):379-91. PubMed ID: 6477682
    [No Abstract] [Full Text] [Related]

  • 2. Effect of streptococcal preparation, OK-432, on experimental infection due to Mycobacterium lepraemurium in mice of C3H/Jms strain.
    Saito H, Tomioka H, Sato K.
    Hiroshima J Med Sci; 1983 Jun 25; 32(2):231-4. PubMed ID: 6352569
    [No Abstract] [Full Text] [Related]

  • 3. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
    Yamamoto A, Nagamuta M, Usami H, Sugawara Y, Watanabe N, Niitsu Y, Urushizaki I.
    Gan To Kagaku Ryoho; 1986 May 25; 13(5):1905-10. PubMed ID: 3707150
    [Abstract] [Full Text] [Related]

  • 4. [Correlation between anti-tumor effect and delayed hypersensitivity induced by topically applied OK-432 with histological findings].
    Kokunai I, Mori T, Yayoi E, Matuura N, Kosaki G.
    Nihon Geka Gakkai Zasshi; 1985 Mar 25; 86(3):258-65. PubMed ID: 3982380
    [Abstract] [Full Text] [Related]

  • 5. [Studies on the hepatoma cell injury by antibody-dependent cell-mediated cytotoxicity and its augmentation by pretreatment of macrophages with OK432].
    Mizoguchi Y, Tsutsui H, Yamamoto S, Morisawa S.
    Arerugi; 1984 Mar 25; 33(3):135-41. PubMed ID: 6466102
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of a streptococcal preparation, OK-432, on murine hematopoietic stem cells.
    Hiraoka A, Yamagishi M, Ohkubo T, Yoshida Y, Uchino H.
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul 25; 44(4):860-3. PubMed ID: 6977253
    [No Abstract] [Full Text] [Related]

  • 8. [Differences in the immunostimulatory activity and antitumor therapeutic effect of OK-432 and N-CWS].
    Mizushima Y, Iwata M, Sato M, Hirata H, Takashima A, Yano S.
    Gan To Kagaku Ryoho; 1986 Jul 25; 13(7):2404-10. PubMed ID: 3729493
    [Abstract] [Full Text] [Related]

  • 9. [Induction and measurement of delayed hypersensitivity to OK-432].
    Kohunai I, Mori T, Yayoi E, Kosaki G.
    Nihon Geka Gakkai Zasshi; 1984 Nov 25; 85(11):1387-92. PubMed ID: 6521720
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Experimental study on the antitumor activity of regional lymph nodes during immunotherapy].
    Kawata H.
    Nihon Geka Gakkai Zasshi; 1984 Nov 25; 85(11):1479-89. PubMed ID: 6521727
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of streptococcal preparation OK-432 on chemically-induced intestinal carcinoma in rats.
    Ichihashi H, Kuzuya H, Kondo T.
    Nagoya J Med Sci; 1980 Mar 25; 42(3-4):49-54. PubMed ID: 7383144
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Correlation between enhancement of natural killer (NK) activity by an immunopotentiator (OK-432) and resistance to human hepatoma cell implantation in nude mice].
    Saito H, Morizane T, Kumagai N, Inagaki Y, Nakamura T, Satoh I, Iino A, Matsumura S, Kawamura N, Tsuchiya M.
    Nihon Shokakibyo Gakkai Zasshi; 1985 Dec 25; 82(12):2923-9. PubMed ID: 3831444
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.